Small Molecule (original) (raw)
Latest News for: small molecule
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for ...
The Facts 10 Jun 2026
BOSTON and SHENZHEN, China, June 10, 2026 /PRNewswire/ -- XtalPi ...
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
PR Newswire 10 Jun 2026
The collaboration focuses on developing a best-in-class small molecule against a G protein-coupled receptor (GPCR) ... Compounding this challenge is the absence of publicly available co-crystal structures of this receptor bound to small-molecule ligands.
ACHIEVE Trials Demonstrate Comparative Benefits of Novel, Small-Molecule Oral GLP-1 RA, Expanding Oral Treatment Options ...
Missoulian 09 Jun 2026
First Head-to-Head Trial Compares Two Oral GLP-1 RAs Effects on Glucose Control and Weight Changes in Type 2 Diabetes ... .
MitoRx Therapeutics presents promising preclinical data on MTRX31, a mitochondrial-targeted small molecule for metabolically unhealthy ...
Nasdaq Globe Newswire 08 Jun 2026
Harwell Oxford, UK – 8 June 2026 ... .
ACHIEVE Trials Demonstrate Comparative Benefits of Novel, Small-Molecule Oral GLP-1 RA, Expanding Oral Treatment Options for Patient Population in Need of Alternative Solutions
PR Newswire 08 Jun 2026
NEW ORLEANS, June 8, 2026 /PRNewswire/ -- New data show the benefits of orforglipron, the first oral, small molecule, non-peptide glucagon-like peptide-1 receptor agonist (GLP-1 RA) to ...
Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portfolio (AstraZeneca plc)
Public Technologies 08 Jun 2026
Elecoglipron is an investigational oral, once-daily, small molecule GLP-1 receptor agonist that mimics the natural GLP-1 hormone.
Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 ...
Magic Valley 06 Jun 2026
AMB-702 demonstrates superior target coverage and efficacy in lean non-human primates ... .
Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate
PR Newswire 06 Jun 2026
("Ambrosia"), today announced preclinical data supporting its small molecule GLP-1 receptor agonist development candidate, AMB-702, in a poster presentation at the American Diabetes Association's (ADA) 86th Scientific Sessions.
HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026
The Eagle-Tribune 04 Jun 2026
BOSTON, June 4, 2026 /PRNewswire/ -- HotSpot Therapeutics, ...
Terremoto Biosciences Granted FDA Fast Track Designation for TER-2013, an AKT1-Selective Small Molecule Inhibitor for ...
Business Wire 03 Jun 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Terremoto Biosciences Granted FDA Fast Track Designation for TER-2013, an AKT1-Selective Small Molecule Inhibitor for Breast Cancer ... .
Sharp Therapeutics Presents New Preclinical Data Supporting Novel Small-Molecule Therapeutic Approach for Niemann-Pick Disease Type C
Nasdaq Globe Newswire 28 May 2026
Novel lead small molecules demonstrate substantial reduction of cholesterol accumulation in NPC patient-derived fibroblasts, with additional data supporting lysosomal health and cellular signaling ... .
Sharp Therapeutics Presents New Preclinical Data Supporting Novel Small-Molecule Therapeutic Approach for Niemann-Pick Disease Type C (Sharp Therapeutics Corp)
Public Technologies 28 May 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132092554) .
MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at ...
Nasdaq Globe Newswire 27 May 2026
Harwell, Oxford, UK – 27 May 2026 ... .
Redwood AI Announces Collaboration with Resilience Biosciences Inc. to Advance AI-Assisted Small-Molecule Drug Development (Redwood AI Corp)
Public Technologies 23 May 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 131976385) .
Redwood AI Announces Collaboration with Resilience Biosciences Inc. to Advance AI-Assisted Small-Molecule Drug Development
ACCESSWIRE 23 May 2026
("Resilience" or "RBI"), a Vancouver-based clinical-stage biopharmaceutical company, to support the development and evaluation of AI-assisted computational chemistry workflows for small-molecule drug development.